Abstract
Background/Objectives: Natural products derived from marine algae serve as promising reservoirs of bioactive compounds for preventing and managing inflammation-associated diseases. This study systematically investigated the regional variations in antioxidant and anti-inflammatory activities of the brown alga Sargassum thunbergii collected from seven coastal regions of Korea and elucidated the underlying mechanisms of action. Methods: Among all samples, the extract from Haeundae-gu exhibited the highest total polyphenol (47.3 ± 2.1 mg GAE/g) and flavonoid (19.8 ± 1.7 mg QE/g) contents, showing superior antioxidant activity in 2,2-diphenyl-1-picrylhydrazyl (DPPH) (RC(50) = 44.54 µg/mL), 2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) (RC(50) = 36.42 µg/mL), and ferric reducing antioxidant power (FRAP) (0.56 mM FeSO(4) eq/mg) assays. In lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages, the Haeundae-gu extract markedly suppressed nitric oxide (NO) production and downregulated inducible nitric oxide synthase (iNOS) expression in a dose-dependent manner without cytotoxic effects. High-performance liquid chromatography (HPLC) identified fucosterol (10.23 ± 0.17 mg/g extract) as a predominant sterol component, and molecular docking analysis revealed specific hydrogen bonding of fucosterol with TYR489 in the active site of iNOS (GlideScore = -4.774 kcal/mol). Results: These findings indicate that both phenolic compounds and sterols such as fucosterol act synergistically to enhance the antioxidant and anti-inflammatory effects of S. thunbergii. Conclusions: In summary, the mechanistic and functional insights obtained in this study highlight S. thunbergii, particularly from Haeundae-gu, as a promising marine-derived bioresource for developing nutraceuticals and therapeutic interventions against oxidative stress and inflammation-related disorders.